These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. Cadogan AK; Alexander SP; Boyd EA; Kendall DA J Neurochem; 1997 Sep; 69(3):1131-7. PubMed ID: 9282935 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of amide and hydrazide analogues of the cannabinoid CB(1) receptor antagonist N-(piperidinyl)- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716). Francisco ME; Seltzman HH; Gilliam AF; Mitchell RA; Rider SL; Pertwee RG; Stevenson LA; Thomas BF J Med Chem; 2002 Jun; 45(13):2708-19. PubMed ID: 12061874 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. Lay L; Angus JA; Wright CE Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647 [TBL] [Abstract][Full Text] [Related]
8. Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine. Pertwee RG; Fernando SR; Nash JE; Coutts AA Br J Pharmacol; 1996 Aug; 118(8):2199-205. PubMed ID: 8864562 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. Lan R; Liu Q; Fan P; Lin S; Fernando SR; McCallion D; Pertwee R; Makriyannis A J Med Chem; 1999 Feb; 42(4):769-76. PubMed ID: 10052983 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids. Ihenetu K; Molleman A; Parsons ME; Whelan CJ Eur J Pharmacol; 2003 Jan; 458(1-2):207-15. PubMed ID: 12498928 [TBL] [Abstract][Full Text] [Related]
11. Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. Griffin G; Fernando SR; Ross RA; McKay NG; Ashford ML; Shire D; Huffman JW; Yu S; Lainton JA; Pertwee RG Eur J Pharmacol; 1997 Nov; 339(1):53-61. PubMed ID: 9450616 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens. Christopoulos A; Coles P; Lay L; Lew MJ; Angus JA Br J Pharmacol; 2001 Mar; 132(6):1281-91. PubMed ID: 11250879 [TBL] [Abstract][Full Text] [Related]
13. Allosteric modulation of the cannabinoid CB1 receptor. Price MR; Baillie GL; Thomas A; Stevenson LA; Easson M; Goodwin R; McLean A; McIntosh L; Goodwin G; Walker G; Westwood P; Marrs J; Thomson F; Cowley P; Christopoulos A; Pertwee RG; Ross RA Mol Pharmacol; 2005 Nov; 68(5):1484-95. PubMed ID: 16113085 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide. Ross RA; Brockie HC; Pertwee RG Eur J Pharmacol; 2000 Aug; 401(2):121-30. PubMed ID: 10924916 [TBL] [Abstract][Full Text] [Related]
15. Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A. Murphy JW; Kendall DA Biochem Pharmacol; 2003 May; 65(10):1623-31. PubMed ID: 12754098 [TBL] [Abstract][Full Text] [Related]
16. O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties. Pertwee RG; Gibson TM; Stevenson LA; Ross RA; Banner WK; Saha B; Razdan RK; Martin BR Br J Pharmacol; 2000 Apr; 129(8):1577-84. PubMed ID: 10780961 [TBL] [Abstract][Full Text] [Related]
17. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. Ross RA; Brockie HC; Stevenson LA; Murphy VL; Templeton F; Makriyannis A; Pertwee RG Br J Pharmacol; 1999 Feb; 126(3):665-72. PubMed ID: 10188977 [TBL] [Abstract][Full Text] [Related]
18. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Gallate JE; Saharov T; Mallet PE; McGregor IS Eur J Pharmacol; 1999 Apr; 370(3):233-40. PubMed ID: 10334497 [TBL] [Abstract][Full Text] [Related]
19. Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain. Burkey TH; Quock RM; Consroe P; Ehlert FJ; Hosohata Y; Roeske WR; Yamamura HI Eur J Pharmacol; 1997 Oct; 336(2-3):295-8. PubMed ID: 9384246 [TBL] [Abstract][Full Text] [Related]
20. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices. Gifford AN; Samiian L; Gatley SJ; Ashby CR Eur J Pharmacol; 1997 Apr; 324(2-3):187-92. PubMed ID: 9145770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]